Like cancer, placental cells multiply rapidly, invade tissues, and evade destruction by the immune system, but maternal ...

A new publication shines a spotlight on HER3, a long-overlooked member of the ErbB receptor family, revealing its critical ...

High-risk neuroblastoma kills roughly half of affected children because the tumor can switch cell identity and evade therapy.

In a recent study published in Developmental Cell, researchers at Karolinska Institutet created a comprehensive map of ...

Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today announces that its Fibroblast Activation Protein (FAP)-targeting therapy candidate, TLX400, has been published in ...

IO Biotech's first-in-class vaccine performs double duty, killing cancer cells and enhancing the tumor microenvironment. A ...

TFS HealthScience (TFS), a leading global Contract Research Organization (CRO), is deepening its collaboration with ...

Genezen, a leading viral vector Contract Development and Manufacturing Organization (CDMO), and Optieum Biotechnologies, Inc. (Optieum), a preclinical stage company dedicated to the discovery and ...

Mammary gland fibroblasts are highly plastic and transition through distinct states during development and disease. A new ...

We are excited to explore a new avenue to treat cancers expressing FAP-α with [ 212 Pb]PSV359," commented Markus Puhlmann, Chief Medical Officer of Perspective. "FAP-α is expressed directly on certain ...

the complex components in the tumor microenvironment (TME) of PC have been gradually revealed. Interactions between pancreatic stellate cells, tumor-associated fibroblasts, various types of immune ...